Literature DB >> 29142155

Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation.

Seimi Satomi-Kobayashi1, Tatsuro Ishida1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29142155      PMCID： PMC5827082          DOI： 10.5551/jat.ED089

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  9 in total

Review 1.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

2.  Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation.

Authors:  Arthur S Leon; Barry A Franklin; Fernando Costa; Gary J Balady; Kathy A Berra; Kerry J Stewart; Paul D Thompson; Mark A Williams; Michael S Lauer
Journal:  Circulation       Date:  2005-01-25       Impact factor: 29.690

3.  Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012).

Authors: 
Journal:  Circ J       Date:  2014-07-22       Impact factor: 2.993

4.  Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway.

Authors:  Chi-Chih Cheng; Chi-Mei Hsueh; Chiu-Yuan Chen; Tzu-Hsiu Chen; Shih-Lan Hsu
Journal:  Biochem Biophys Res Commun       Date:  2013-06-20       Impact factor: 3.575

5.  Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control.

Authors:  N Carbó; J López-Soriano; P Costelli; B Alvarez; S Busquets; F M Baccino; L S Quinn; F J López-Soriano; J M Argilés
Journal:  Biochim Biophys Acta       Date:  2001-04-03

6.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Authors:  Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Journal:  JAMA       Date:  2009-04-08       Impact factor: 56.272

7.  Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.

Authors:  Shinji Koba; Makoto Ayaori; Harumi Uto-Kondo; Fumiaki Furuyama; Yuya Yokota; Fumiyoshi Tsunoda; Makoto Shoji; Katsunori Ikewaki; Youichi Kobayashi
Journal:  J Atheroscler Thromb       Date:  2016-03-05       Impact factor: 4.928

8.  Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling.

Authors:  Hong Tang; Ruili Yu; Shiying Liu; Bahetiyaer Huwatibieke; Ziru Li; Weizhen Zhang
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143

9.  Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.

Authors:  Fumiaki Furuyama; Shinji Koba; Yuya Yokota; Fumiyoshi Tsunoda; Makoto Shoji; Youichi Kobayashi
Journal:  J Atheroscler Thromb       Date:  2017-08-30       Impact factor: 4.928
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.